John Lunger
Corporate Officer/Principal at ADAPTIMMUNE THERAPEUTICS PLC
Net worth: 162 784 $ as of 2024-05-30
John Lunger active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 2017-02-28 | - |
Career history of John Lunger
Former positions of John Lunger
| Companies | Position | Start | End |
|---|---|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
| GENOCEA BIOSCIENCES, INC. | Director/Board Member | 2022-03-02 | - |
| Independent Dir/Board Member | 2022-03-02 | - |
Training of John Lunger
| United States Naval Academy | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistics
International
| United States | 5 |
| United Kingdom | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- John Lunger
- Experience
